...
首页> 外文期刊>JACC. Cardiovascular interventions >Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery
【24h】

Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery

机译:ST段抬高型心肌梗死患者先前行冠状动脉搭桥手术的主要经皮冠状动脉介入治疗的结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives This study sought to determine the contemporary clinical characteristics and outcomes of patients with ST-segment elevation myocardial infarction (STEMI) and previous coronary artery bypass graft (CABG), including those with a saphenous vein graft culprit lesion.Background The outcome of STEMI patients with previous CABG is reported to be inferior to those without previous CABG, but limited data is available from the primary percutaneous coronary intervention era.Methods Data was extracted from a large, regional STEMI system's prospective database, which contained 3,542 unique STEMI episodes from March 4, 2003 through April 22, 2012.Results Previous CABG was present in 249 patients (7%). Despite higher comorbidity, patients with versus those without previous CABG had similar in-hospital (4.8% vs. 5.2%; p = 0.82) and 1-year (10.8% vs. 9.1%; p = 0.36) mortality, but 5-year (24.9% vs. 14.2%; p < 0.001) mortality was higher. Patients with previous CABG have similar door-to-balloon times. The culprit vessel was the saphenous vein graft in 84 patients (34%), a native vessel in 104 (42%), with no clear culprit in 59 (24%). The left internal mammary artery graft was not a culprit in any patient. Mortality at 30 days (8.3% vs. 3.9% vs. 1.7%, p = 0.19) and 1 year (14.3% vs. 9.0% vs. 6.8%; p = 0.35) was higher (but not statistically) with a saphenous vein graft culprit and was equivalent at 5 years (25.0% vs. 26.0% vs. 20.3%; p = 0.71).Conclusions Patients with previous CABG treated in a regional STEMI system have similar outcomes as patients without previous CABG, although 5-year mortality is higher. The most common culprit location was a native vessel (42%). Outcomes have improved significantly compared with historical reports.
机译:目的本研究旨在确定ST段抬高型心肌梗死(STEMI)和既往冠状动脉搭桥术(CABG)的患者(包括隐静脉移植罪魁祸首病变的患者)的当代临床特征和预后。以前使用CABG的患者据报道不如未使用过CABG的患者,但主要经皮冠状动脉介入治疗时代的数据有限。方法数据摘自区域性大型STEMI系统的前瞻性数据库,该数据库自3月4日起包含3,542例独特的STEMI发作,从2003年到2012年4月22日。结果先前的CABG存在于249例患者中(7%)。尽管合并症较高,但有或没有CABG的患者院内死亡率分别为(4.8%比5.2%; p = 0.82)和1年(10.8%比9.1%; p = 0.36),但为5年(24.9%vs. 14.2%; p <0.001)死亡率更高。先前患有CABG的患者上气球时间相似。罪魁祸首是84例患者(34%)的大隐静脉移植,104例(42%)的自然血管,59例(24%)无明显的罪魁祸首。左乳内动脉移植物不是任何患者的罪魁祸首。隐静脉的30天死亡率(8.3%vs. 3.9%vs. 1.7%,p = 0.19)和1年死亡率(14.3%vs. 9.0%vs. 6.8%; p = 0.35)更高(但无统计学意义)移植罪魁祸首,并在5年时等效(25.0%vs. 26.0%vs. 20.3%; p = 0.71)。结论尽管在区域性STEMI系统中接受过CABG治疗的患者的5年死亡率与未接受CABG的患者相似。更高。最常见的罪魁祸首是本地船只(42%)。与历史报告相比,结果显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号